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Occupational asthma (OA) is a heterogeneous disease, and the characteristics of the sensitizer responsible for OA may induce
diﬀerent clinical, functional, and biological manifestations. We examined the characteristics of 74 patients with OA induced
by low molecular weight compounds (LMWC) or by high molecular weight compounds (HMWC) and diagnosed by speciﬁc
inhalation challenge (SIC). Patients with OA induced by LMWC had a longer occupational exposure before the beginning of
symptoms, a lower sputum eosinophilia,and a higher prevalence of late airway response (LAR), in comparison with patients with
OA induced by HMWC. Pulmonary function tended to be poorer and atopy tended to be less frequent in LMWC-induced OA
than in HMWC-induced OA. These data conﬁrm and extend previous observations showingthat the characteristics of the speciﬁc
sensitizer inducing OA may determine diﬀerent clinical, functional, and biological features, probably related to the diﬀerence
pathogenetic mechanisms underlying these diﬀerent types of OA.
1.Introduction
Occupational asthma with latency period can be induced
by sensitization to either a speciﬁc allergen (high molecu-
lar weight compounds, HMWC) or chemical compounds
(low molecular weight compounds, LMWC) present in the
workplace [1]. The gold standard for the diagnosis of OA is
represented bythe SpeciﬁcInhalation Challenge(SIC)which
is intended to demonstrate a direct relationship between
exposure to a speciﬁc agent present in the workplace and
an asthmatic response [2]. Few studies have analysed the
variable patterns of response to HMWC and LMWC (early,
dual, or late response) in limited numbers of patients, but
how worker’s characteristics may inﬂuence the pattern of
response to the sensitising agents remains to be explored.
Recent studies [3] have shown that there are signiﬁcant
diﬀerences in the type of airway changes induced by low and
high molecular weight agents.
Sputum eosinophilia has been reported in a variable
percentage of patients aﬀected by occupational asthma, and
some studies suggested that patients with asthma induced
by LMWC may have a lower sputum eosinophil percentage
than patients with asthma due to HMWC [4, 5]. Sputum
eosinophils increase further after exposure to both HMWC
and LMWC, showing the increase in allergic airway inﬂam-
mation induced by these speciﬁc sensitizers [6]. Factors that
i n ﬂ u e n c et h et y p eo fi n ﬂ a m m a t o r yr e s p o n s e sa r eu n c l e a r
but may include also the type of asthmatic reaction and
the intensity of airway inﬂammation. In particular, it is not
knownifthe typeand/orthe severityofairway inﬂammation
may contribute to the determination of the pattern of airway
response to the speciﬁc sensitizer.
We compared the clinical characteristics, the airway
inﬂammatory pattern, and the model of speciﬁc airway
response in patients with OA induced by HMWC or LMWC.
The aim was to assess, in this speciﬁc model of asthma,
whether the characteristics of the sensitizer and the diﬀerent
pathophysiologic mechanisms may be associated with a
diﬀerent asthma phenotype.2 Journal of Allergy
2.Materialsand Methods
We studied 74 subjects with occupational asthma due to dif-
ferentsensitizers (diisocyanates, latex, hairdresser’s products,
wood, and ﬂour dusts) observed consecutivelyin ourasthma
clinic: 48 were exposed to LMWC (isocyanates, persulfate
salts, aziridine, and phenolic resins) agents, and 26 were
exposed to HMWC (ﬂour dusts, wood dusts, latex, deter-
gents,and tobaccodusts).We selected onlysubjectsinwhom
thediagnosis ofoccupationalasthma had been performed by
means of positive response to speciﬁc inhalation challenge
(SIC). According to the international recommendations [2,
7], patients were all exposed to a known occupational
sensitizer (Table 1)showed asthma deteriorationatwork and
nonspeciﬁc bronchial hyperresponsiveness during a working
period.
Bronchial hyperresponsiveness was determined by meth-
acholine challenge test performed as previously reported [8];
a provocative dose of a 20% decrease in FEV1 from baseline
(PD20FEV1)oflessthan1000mcgwasconsideredaspositive
for bronchial hyperresponsiveness.
SIC was performed using diﬀerent methods (Table 1):
(a) for diisocyanates, subjects were exposed to vapours
generated by blowing air on the surface of a small amount
of toluenediisocyanate (TDI) or warming a small amount of
methylenediphenyl diisocyanate (MDI) at 40◦C, in a chal-
lenge chamber and monitoring isocyanate concentrations
with a speciﬁc TDI/MDI detector (MDA model 7005 iso-
cyanate detectionequipment,MDAScientiﬁcInc., Glenview,
IL); diluent was used as control exposure; the duration of
t h ee x p o s u r ew a s3 0 m i ni naﬁ r s tt e s ta n d1 2 0 m i ni na
second test (if the ﬁrst resulted negative) [9]; (b) for dusts
(ﬂour, wood, persulfate, latex, and tobacco),subjects inhaled
dusts by a mouthpiece connected to a small box where a
suspension of the dust was obtained by blowing compressed
air at 5L/min through a bottle containing the dust; lactose
powder was used as control test; the concentration of the
dusts was measured by blowing air from the box through
a cellulose nitrate ﬁlter of 0.8µm porosity by means of
a vacuum pump [10]; (c) in two cases (one exposed to
phenolic resins and the other to detergents), a realistic
way was employed in order to simulate in laboratory the
exposure of the workplace (spreading the substance on a
small surface); diluent was used as control test, and the
duration of exposure was still 30 minutes. In all SIC, FEV1
was measured immediately before and 5, 15, 30, and 60
m i n u t e sa f t e rt h ee x p o s u r et ot h es e n s i t i z e r ,t h e nh o u r l y
for 8 hours. A positive response was deﬁned as a decrease
in FEV1 from baseline of more than 15% during the ﬁrst
hour (immediate response) or between the second and the
8th hour (late response), and in absence of a more than
10% decrease in FEV1 during a control test performed in a
diﬀerent day with diluent (for diisocyanates or other simple
chemicals) or with lactose dust (for other dust sensitizers).
One or two weeks before challenge, other measurements
at diagnosis included skin prick tests to common allergens
(to check for atopy), and collection of sputum induced by
the inhalation of saline solution. The method for induction








Figure 1: Type ofresponse to SIC in subjects sensitized to high and






































Figure 2: Magnitude of the early (EAR) and late (LAR) responses
(expressed as percent decrease in FEV1 from baseline) during SIC
to low (LMWC) or high (HMWC) molecular weight compounds,
∗P<. 05.
and diﬀerential counts of inﬂammatory cells (eosinophils,
macrophages, neutrophils, and lymphocytes) were consid-
ered; we chose 2% as the upper limit of normal range for
sputum eosinophils [12].
All patients gave their informed consent to the manage-
ment of their personal data.
Characteristics of subjects (age, sex, smoking habit,
atopy, duration of symptoms and exposure, latency, type of
response, sputum eosinophilia, and functional data) were
compared between two groups with asthma induced by
HMWC or LMWC.
Descriptive analysis for data collected at diagnosis was
performed, with data expressed as mean (+standard devia-
tion, SD) or median (range) for normally and nonnormally
distributed data, respectively. PD20FEV1 methacholine wasJournal of Allergy 3
Table 1:Characteristics ofthe compounds used forperformingspeciﬁc inhalationtests (SIC),concentrationsused during SICandduration
of the exposure.
Agent Control Number of subjects Challenge concentration Time exposure
TDI vapours Diluent 37 0.002–0.003ppm 30–120 
Flour dust Lactose dust 20 0.3–0.5mg/m3 30 
Wood dusts Lactose dust 3 0.3–0.5mg/m3 30 
Persulfate salts Lactose dust 6 0.05–0.1mg/m3 30 
Aziridine Lactose dust 2 0.03–0.05mg/m3 30 
Latex solution Normal saline 3 <0.0001mg/m3 30 
Tobacco dusts Lactose dust 1 0.3–0.5mg/m3 30 
Phenolic resins and Detergents vapours Diluent 2 Not measured∗ 30 
∗Subjects simulated the job activity in laboratory.
Table 2: Characteristics of the patients examined, according to the
type of the occupational sensitizer.
LMWC HMWC
Patients 48 26
Age, years 43.8 ±12.03 8 .9 ±10.8
Gender,
Male 34 (70.8) 20 (76.9)
Female 14 (29.2) 6 (23.0)
Atopy 12 (25) 12 (46.1)
Smokinghabit
Nonsmokers, N (%) 23 (47.9) 14 (53.8)
Smokers,N (%) 4 (8.3) 2 (7.7)
Ex-smokers, N (%) 21 (43.8) 10 (38.4)
Therapy N/Y 29/19 14/12
Duration of symptoms, yrs 6.1 ±6.96 .4 ±5.7
Duration of exposure, yrs 20.1 ±13.11 5 .2 ±7.7∗
Latency period, yrs 13.9 ±12.78 .7 ± 5.7∗
Baseline FEV1
L3 .01 ±0.67 3.39 ± 0.68∗
%p r e d 8 9 .2 ±16.09 3 .5 ±14.8
Baseline PD20FEV1 (mg) 0.22 (0.01–5.00) 0.18 (0.02–5.00)
Sputum eosinophilia
Eosinophils,% 0.95 (0–32) 6.8 (0–43.1)∗
Data are presented as n (%),M±SD or GM (range; PD20FEV1) or median
(range; eosinophils, %).
∗P<. 05.
LMWC: low molecular weight compound; HMWC: high molecular weight
compound.
reported as geometric mean and log-transformed for sta-
tistical analysis. Comparison among groups was performed
by appropriate parametric (analysis of variance, Chi-square
test, and unpaired t-test) and nonparametric tests (Mann-
Whitney U test). A P value lower than 5% was considered as
signiﬁcant, and a P value between 0.1 and.05 was considered
as expression of a trend.
3.Results
Patients’ characteristics are summarized in Table 2.T h e s e
characteristics were similar in both groups with asthma
induced by HMWC and LMWC, except for duration of
exposure,latencyperiod,andsputumeosinophilia.Duration
of exposure and latency periods were higher in subjects
with asthma due to LMWC, who had also a lower sputum
eosinophilia. FEV1 was lower in absolute value, but not
in percentage of predicted, in patients with LMWC- than
in patients with HMWC-induced asthma. Atopy was more
frequently observed in patients with HMWC- than in
patients with LMWC-induced asthma, but the diﬀerence
was not statistically signiﬁcant. Atopic subjects had a higher
FEV1 (P = .02) and a higher percentage of eosinophils
(P = .005).
The comparison among groups of subjects with asthma
due to diﬀerent sensitizers was strongly aﬀected by the low
number of subjects included in the diﬀerent groups, except
for patients sensitized to diisocyanates (N = 37) and to ﬂour
dust (N = 20) who were diﬀerent for age, atopy, duration
of exposure, and sputum eosinophil percentage, in the same
way as the diﬀerence between LMWC and HMWC. There
was also a diﬀerence in the gender, related to the speciﬁc jobs
(e.g., female in the subjects exposed to persulfate, or male in
subjects exposed to diisocyanates).
Patterns of response following SIC were diﬀerent for
HMWC and LMWC. Subdividing subjects by type of
response, immediate responses (early + dual response) were
common in subjects exposed to HMWC (Figure 1). Also,
in subjects with higher sputum eosinophilia, immediate
responses were higher (61.1% versus 94.1%, P = .02).
Considering all types of responses, magnitude of the early
(EAR) responses was higher during SIC to LMWC while the
magnitudeofthelate(LAR)responseswashigherduringSIC
to HMWC (Figure 2).
4.Discussion
The present study shows that few clinical characteristics may
diﬀerentiate patients with occupational asthma induced by
LMWC from those with asthma induced by HMWC. In
particular, duration of exposure before the beginning of
asthma symptoms and the severityof the eosinophilic airway
inﬂammation were the only ﬁndings which diﬀerentiated
two groups of patients. In the same way, the pattern or
airway response was consistentlydiﬀerent,withpatientswith
LMWC-induced asthma showing a higher frequency and4 Journal of Allergy
a greater severity of the isolated LAR than patients with
HMWC-induced asthma who showed, on the contrary, a
greater frequency and severity of the early response. These
data conﬁrm and extend previous observations conﬁrming
that some clinical and functional characteristics are diﬀerent
between subjects with occupational asthma induced by
LMWC or by HMWC.
O u ro b s e r v a t i o n sc o n c e r naw ide range of sensitizing
agents and a consistent number of subjects, as in other
previous few studies [3, 13]. Diﬀerently from other previous
papers which have considered only a subset of baseline mea-
surements, our data include several clinical and functional
ﬁndings which may be measured in these patients, including
also the evaluation of the level of eosinophilic airway
inﬂammation and the pattern of response to SIC. In eﬀect,
previous studies have shown that patients with LMWC-
induced asthma had a greater duration of exposure to the
speciﬁc sensitizer before the beginning of asthma symptoms
than patients with HMCW-induced asthma [14, 15], or that
LMWC asthma showed less frequent sputum eosinophilia
[5]o ral o w e rf r e q u e n c yo fi m m e d i a t ea i r w a yr e s p o n s et o
SIC [3, 16]. All these data have been conﬁrmed in our
study which included a large set of clinical, functional, and
biological ﬁndings of the disease at the baseline assessment.
However, other studies did not show relevant diﬀerence
in terms of type and level of airway inﬂammation, level of
asthma severity at the diagnosis, or rate of recovery from
asthma after work cessation, between asthma induced by
HMWC or LMWC [17–20]. However, some of these studies
includedsmall number ofsubjects, with severalconfounding
factors (like the persistence or removal from exposure, or the
severity of the disease).
This diﬀerence in clinical, functional, and biological
features is probably related to the diﬀerent pathophysiologic
mechanisms underlying HMWC and LMWC occupational
asthma [21]. Despite the large heterogeneity of the patho-
genetic mechanisms underlying this disease, OA induced
by HMWC is sustained by an IgE-mediated mechanism,
which is well know to induce immediate airway reaction,
due to mastcell activation which initiates the inﬂammatory
cascade leading to a late reaction and the recruitment
of eosinophils in the airways. Diﬀerently, LMWC elicit a
lymphocyte-speciﬁc sensitization, with predominant iso-
lated late response and lower eosinophilic inﬂammation.
Thesefeatures,inadditiontothelongerdurationofexposure
before the beginning of symptoms and the lower pulmonary
function, make LMWC-induced asthma as a good model of
late-onset asthma, diﬀerent from HMWC-induced asthma
which has many ﬁndings more typical ofearly-onset asthma.
The hypothesis of diﬀerent characteristics and outcome
between early- and late-onset asthma has been suggested
by other authors [22] and might be further supported
by the diﬀerent outcome of asthma after removal from
work exposure. In eﬀect, independently from the speciﬁc
characteristics of the occupational agent, patients who at
diagnosis had higher levels of sputum eosinophila reported
a better outcome in the followup than patients without
sputum eosinophilia, probably because a better response to
the corticosteroid treatment [23].
5.Conclusions
In summary, we may speculate that the chemical charac-
teristics of the speciﬁc sensitizer responsible for OA are
responsible for a diﬀerent pathophysiologic mechanism,
which may determine diﬀerent clinical, functional, and
biological manifestation of the disease, including the pattern
of speciﬁc airway response. In this way, occupational asthma
may represent a good model for studying the heterogeneity
of asthma and the diﬀerence between early- and late-onset
asthma.
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